Tobrutinib (pirtobrutinib) Indian drug price and purchase channels

Pirtobrutinib (Pirtobrutinib), as a new type of BTK inhibitor, is mainly used to treat certain types of lymphoma and hematological malignancies. As of now, pitobrutinib has not been officially launched in mainland China, and domestic patients are temporarily unable to purchase this drug directly through formal channels. Due to its remarkable efficacy, patients have great demand for this drug. However, due to the domestic drug approval process, the ways to purchase the drug are relatively limited.

There is currently no Indian generic version of Pitobrutinib on the market, which means patients cannot purchase the drug at a lower price through Indian channels. Compared with Indian generic versions of some common targeted drugs, there is no legal generic supply of pitobrutinib in the Indian market, which is a major limitation for patients who want to find affordable medication options.

In overseas markets, pitobrutinib has two versions: original drug and generic version, with a large price gap. For example, the specifications of the original research version in the US market are 50mg*30 tablets, and the price is as high as about 10 RMB. The price is relatively expensive, which puts great financial pressure on patients.相比之下，老挝市场的仿制版本价格亲民，仅需2000多元人民币，成为部分患者的替代选择。

Since Pitobrutinib cannot be purchased directly in China, if patients need medicine, they can obtain the medicine through legal overseas procurement channels, but they need to ensure that the channels are formal to avoid the risk of counterfeit medicines. It is recommended that patients evaluate treatment options under the guidance of a doctor and choose a suitable drug version based on their own financial situation and actual needs. At the same time, attention is paid to domestic drug approval developments. It is expected that domestically produced or imported drugs will be launched in the future, further improving the convenience and accessibility of medication.

Reference materials:https://www.drugs.com/

xa0